Spontaneous platelet aggregation in cerebrovascular disease.
50 patients from a group of 130 patients with transient ischaemic attacks or cerebral infarction were found to demonstrate in vitro spontaneous platelet aggregation (SPA) while 80 normal subjects tested never showed this phenomenon. The following additional findings point towards a possible platelet abnormality: 1. Platelets from 10 patients with SPA when isolated and resuspended in normal plasma still demonstrated SPA while isolated normal platelets resuspended in patient's plasma did not. 2. Platelets demonstrating SPA showed an increased aggregation tendency upon incubation with ADP while normal platelets developed the expected refractory state. SPA was found to be dependant upon the presence of divalent cations and could further be inhibited by phentolamine and adenosine. Aspirin effectively abolished SPA in 50 patients and relieved the clinical symptoms of patients with recurrent complaints of transient blindness and paraesthesia.
D000241:Adenosine / Q000494:pharmacology; D000244:Adenosine Diphosphate; D000328:Adult; D000368:Aged; D001241:Aspirin / Q000627:therapeutic use; D001766:Blindness / Q000188:drug therapy; D001927:Brain Diseases / Q000097:blood; D005260:Female; D006801:Humans; D002546:Ischemic Attack, Transient / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010292:Paresthesia / Q000188:drug therapy; D010646:Phentolamine / Q000494:pharmacology; D010974:Platelet Aggregation
D000244:Adenosine Diphosphate; D000241:Adenosine; D001241:Aspirin; D010646:Phentolamine